Clinical Trials Directory

Trials / Sponsors / COMPASS Pathways

COMPASS Pathways

Industry · 8 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingEfficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD
Treatment Resistant Depression
Phase 32023-02-14
Active Not RecruitingA Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, P
Major Depressive Disorder
Phase 22023-01-30
Active Not RecruitingEfficacy, Safety, and Tolerability of COMP360 in Participants With TRD
Treatment Resistant Depression
Phase 32023-01-19
CompletedEfficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept Study
Anorexia Nervosa
Phase 22022-10-12
CompletedThe Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder
Post Traumatic Stress Disorder
Phase 22022-06-10
CompletedThe Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depres
Treatment Resistant Depression
Phase 22020-08-10
CompletedLong Term Follow Up Study to COMP 001 And COMP 003 Trials (P-TRD LTFU)
Treatment Resistant Depression
—2020-07-20
CompletedThe Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression
Treatment Resistant Depression
Phase 22019-03-01